37 completed, 5 terminated, 3 unknown, 2 withdrawn. 49 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 49 | Completed 37, Terminated 5, Unknown 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1 |
Follow Renal Transplantation: new trials by email Literature Review of Renal Transplantation trials Research Report on Renal Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine and Kidney Transplantation Dexmedetomidine - Renal Transplantation, Dexmedetomidine | Phase 4 | Not yet recruiting | Eduardo Schiffer | 206 | 2024-12-01 | 2024-05-08 |
| Acthar for Treatment of Post-transplant FSGS Acthar - FSGS, Renal Transplantation | Phase 4 | Withdrawn | University of North Carolina, Chapel Hill | 2021-03-01 | 2021-08-30 | |
| Envarsus XR® in Adolescent Renal Transplant Recipients Envarsus XR, Tacrolimus - Kidney Transplantation, Renal Transplantation | Phase 4 | Active not recruiting | University of California, Los Angeles | 28 | 2019-01-15 | 2023-02-09 |
| Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. Cholecalciferol vial (100 000 UI) - Chronic Kidney Disease, Renal Transplantation | Phase 4 | Completed | Hospices Civils de Lyon | 43 | 2014-09-01 | 2025-09-04 |
| The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients antimicrobial treatment according to in-vitro susceptibility - Urinary Tract Infection, Bacteriuria | Phase 4 | Unknown | Rabin Medical Center | 2014-04-01 | 2014-04-15 | |
| Computer Guided Doing of Tacrolimus in Renal Transplantation Computer dosing, Standard dose determination - Renal Transplantation | Phase 4 | Completed | University of Oslo School of Pharmacy | 80 | 2014-01-01 | 2014-12-03 |
| Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) Induction therapy, Corticosteroids, EVR+rCNI - End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD) | Phase 4 | Completed | Novartis Pharmaceuticals | 2037 | 2013-12-03 | 2019-01-30 |
| A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) Mycophenolate sodium, Mycophenolate mofetil - Renal Transplantation | Phase 4 | Completed | Irmandade Santa Casa de Misericórdia de Porto Alegre | 100 | 2013-04-01 | 2015-04-03 |
| Belatacept Early Steroid Withdrawal Trial Alemtuzumab, rabbit antithymocyte globulin, Belatacept - Renal Transplantation | Phase 4 | Completed | University of Cincinnati | 316 | 2012-09-01 | 2026-07-24 |
| Hepatitis C in Renal Transplant Recipients tacrolimus-cyclosporine A - Chronic Hepatitis C-virus Infection, Renal Transplantation | Phase 4 | Unknown | Prof. Dr. Alice Schmidt | 30 | 2011-12-01 | 2014-04-11 |
| AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation Advagraf Capsule, Prograf Capsule - Renal Transplantation | Phase 4 | Completed | Centre Hospitalier Universitaire de Nice | 45 | 2011-10-01 | 2026-03-31 |
| A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients ADVAGRAF, PROGRAF - Renal Transplantation, Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Korea, Inc. | 100 | 2011-04-01 | 2014-08-05 |
| Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation everolimus - Renal Transplantation | Phase 4 | Terminated | Dianet Dialysis Centers | 13 | 2010-09-01 | 2017-08-07 |
| Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation Myfortic (mycophenolic acid), Thymoglobulin (anti-thymocyte globulin) - Kidney Transplantation, Renal Transplantation | Phase 4 | Withdrawn | Georgetown University | 2010-06-01 | 2014-06-09 | |
| Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program Basiliximab, Enteric Coated Mycophenolic Acid (MPA), RAD001 - Renal Transplantation | Phase 4 | Terminated | Novartis Pharmaceuticals | 207 | 2009-07-01 | 2014-06-06 |
| Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation Tacrolimus - Renal Transplantation | Phase 4 | Completed | The Second Artillery General Hospital | 145 | 2009-07-01 | 2011-12-22 |
| Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation cyclosporine, Everolimus - Renal Transplantation | Phase 4 | Unknown | University Hospital, Antwerp | 152 | 2008-10-01 | 2009-05-18 |
| Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation Iminoral, Neoral - End Stage Renal Disease, Renal Transplantation | Phase 4 | Completed | Imam Khomeini Hospital | 208 | 2008-04-01 | 2012-06-22 |
| A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms Enteric-coated Mycophenolate Acid (EC-MPA), Mycophenolate Mofetil (MMF), Placebo MMF - Renal Transplantation | Phase 4 | Terminated | Novartis Pharmaceuticals | 30 | 2008-03-01 | 2012-08-07 |
| Interaction Between Rimonabant and Cyclosporine and Tacrolimus cyclosporine A, tacrolimus - Renal Transplantation | Phase 4 | Completed | University of Oslo School of Pharmacy | 18 | 2007-09-01 | 2014-12-03 |
Showing 20 of 49. Sign in to see all of them.
Kidney Failure, Chronic (2) · Rejection, Psychology (2) · Renal Insufficiency (2) · Renal Insufficiency, Chronic (2) · Anemia (1) · Bacteriuria (1) · Delayed Graft Function (1) · Neoplasms (1) · Nephrotic Syndrome (1) · Obesity (1) · Reperfusion Injury (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Kidney Diseases (4) · Pathologic Processes (4) · Chronic Disease (3) · Disease Attributes (3) · Behavior (2) · Renal Insufficiency (2) · Social Behavior (2) · Body Weight (1) · Cardiovascular Diseases (1)
Mycophenolic Acid (15) · Tacrolimus (13) · Everolimus (11) · Cyclosporine (10) · Adrenal Cortex Hormones (6) · Basiliximab (4) · thymoglobulin (4) · Prednisone (3) · Sirolimus (3) · Alemtuzumab (2) · Antilymphocyte Serum (2) · Fluvastatin (2) · Methylprednisolone (2) · Steroids (2) · Abatacept (1)
Novartis Pharmaceuticals (10) · Novartis (8) · University of Oslo School of Pharmacy (4) · Astellas Pharma Inc (3) · University Hospital Schleswig-Holstein (2) · Astellas Pharma Korea, Inc. (1) · California Pacific Medical Center Research Institute (1) · Centre Hospitalier Universitaire de Nice (1) · Centre Hospitalier Universitaire, Amiens (1) · Charite University, Berlin, Germany (1) · Dianet Dialysis Centers (1) · Eduardo Schiffer (1) · Georgetown University (1) · Hospices Civils de Lyon (1) · Imam Khomeini Hospital (1)
United States (11) · Switzerland (8) · Germany (7) · France (5) · Norway (5) · Belgium (3) · Austria (2) · Brazil (2) · Netherlands (2) · South Korea (2) · Argentina (1) · Australia (1) · Bulgaria (1) · Canada (1) · Chile (1)
Lutz Renders, MD (2) · Bruna Cardoso, Pharmacist (1) · Daniela Seelig, Physician (1) · E. Steve Woodle, MD (1) · Elizete Keitel, Physician (1) · Fabiano Klaus, Physician (1) · Franck Martinez, MD, PhD (1)
PMID 16123718, PMID 18021971, PMID 18091520, PMID 18339140, PMID 18793527, PMID 19307792, PMID 19339089, PMID 19843296, PMID 21334736, PMID 21693250, PMID 21981661, PMID 22193388, PMID 22471345, PMID 23351013, PMID 23369437, PMID 23423269, PMID 24477186, PMID 25070687, PMID 25886918, PMID 26086833, PMID 26735686, PMID 29149958, PMID 29752413, PMID 29954336, PMID 30231851, PMID 31152476, PMID 31415033, PMID 31536556, PMID 31873802, PMID 32633157, PMID 33277746, PMID 34216395, PMID 34233921, PMID 34620664, PMID 36094829, PMID 36791280, PMID 40704545
2005 (1), 2008 (1), 2009 (1)